A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes

Clinical Nutrition

Volumn 32, Issue 6, 2013, Pages 911-917

  Ataie Jafari, Asal ^a,b   Loke, Seng Cheong ^b   Rahmat, Asmah B ^b   Larijani, Bagher ^a   Abbasi, Farzaneh ^a   Leow, Melvin K S ^c,d   Yassin, Zaitun ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c AGENCY FOR SCIENCE   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

C Peptide; Diabetes mellitus; Hydroxycholecalciferols; Insulin secreting cells; Iran; Randomized controlled trial; Type 1

Indexed keywords

25 HYDROXYVITAMIN D; ALFACALCIDOL; C PEPTIDE; CALCIUM; HEMOGLOBIN A1C; INSULIN; PHOSPHATE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; AGE; ARTICLE; CALCIUM BLOOD LEVEL; CHILD; CONTROLLED STUDY; DAILY INSULIN DOSAGE PER BODY WEIGHT; DRUG EFFICACY; DRUG STABILITY; FEMALE; GENDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SELF MONITORING; SEX DIFFERENCE; SIDE EFFECT; SINGLE BLIND PROCEDURE; SUN EXPOSURE; VITAMIN SUPPLEMENTATION;

1-ALPHA-HYDROXYCHOLECALCIFEROL; ALFACALCIDOL; C-PEPTIDE; DAILY INSULIN DOSAGE PER BODY WEIGHT; DIABETES MELLITUS; DID; FASTING C-PEPTIDE; FCP; GLM-ANOVA; GLYCATED HEMOGLOBIN; HBA1C; HLA; HUMAN LEUKOCYTE ANTIGEN; HYDROXYCHOLECALCIFEROLS; INSULIN-SECRETING CELLS; IRAN; MULTIVARIATE GENERAL LINEAR MODELING REPEATED MEASURES ANOVA; RANDOMIZED CONTROLLED TRIAL; SELF-MONITORED BLOOD GLUCOSE; SMBG; T1DM; TYPE 1; TYPE 1 DIABETES; VDR; VITAMIN D RECEPTOR;

ADOLESCENT; BLOOD GLUCOSE; BODY WEIGHT; C-PEPTIDE; CALCIUM, DIETARY; CHILD; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHOLECALCIFEROLS; HYPERCALCEMIA; INSULIN; INSULIN-SECRETING CELLS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; SINGLE-BLIND METHOD;

EID: 84887628418     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.01.012     Document Type: Article

References (34)

1. Tao B., Pietropaolo M., Atkinson M., Schatz D., Taylor D. Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method. PLoS One 2010, 5:e11501.
2. Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., LaPorte R., et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000, 23:1516-1526.
3. Picardi A., Visalli N., Lauria A., Suraci C., Buzzetti R., et al. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes. Horm Metab Res 2006, 38:668-672.
4. Haller M.J., Atkinson M.A., Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin North Am 2005, 52:1553-1578.
5. Riachy R., Vandewalle B., Moerman E., Belaich S., Lukowiak B., et al. 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 2006, 11:151-159.
6. Szodoray P., Nakken B., Gaal J., Jonsson R., Szegedi A., et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008, 68:261-269.
7. Motohashi Y., Yamada S., Yanagawa T., Maruyama T., Suzuki R., et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. JClin Endocrinol Metab 2003, 88:3137-3140.
8. Ponsonby A.L., Pezic A., Ellis J., Morley R., Cameron F., et al. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol 2008, 168:358-365.
9. Bourlon P.M., Billaudel B., Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. JEndocrinol 1999, 160:87-95.
10. Pishdad G.R. Low incidence of type 1 diabetes in Iran. Diabetes Care 2005, 28:927-928.
11. Rabbani A., Abbasi F., Taghvaei M., Rabbani B., Moradi B., et al. HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I. Pediatr Diabetes 2012.
12. Bener A., Alsaied A., Al-Ali M., Hassan A.S., Basha B., et al. Impact of lifestyle and dietary habits on hypovitaminosis D in type 1 diabetes mellitus and healthy children from Qatar, a sun-rich country. Ann Nutr Metab 2008, 53:215-222.
13. Moltchanova E.V., Schreier N., Lammi N., Karvonen M. Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide. Diabet Med 2009, 26:673-678.
14. Roche, LEO Pharmaceutical. Rocalctrol and one-Alfa drug information pamphlets.
15. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011, CD007470.
16. Pitocco D., Crino A., Di Stasio E., Manfrini S., Guglielmi C., et al. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med 2006, 23:920-923.
17. Bizzarri C., Pitocco D., Napoli N., Di Stasio E., Maggi D., et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010, 33:1962-1963.
18. Li X., Liao L., Yan X., Huang G., Lin J., et al. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2009, 25:411-416.
19. Gabbay M.A., Sato M.N., Finazzo C., Duarte A.J., Dib S.A. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual beta-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 2012, 166:601-607.
20. American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract 2010, 16:155-156.
21. Type 1 diabetes in adults: national clinical guideline for diagnosis and management in primary and secondary care. 2011/09/23 2004, National Collaborating Centre for Chronic Conditions (UK), Royal College of Physicians, London, UK.
22. Payne R.B., Carver M.E., Morgan D.B. Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. JClin Pathol 1979, 32:56-60.
23. Glanz K., Yaroch A.L., Dancel M., Saraiya M., Crane L.A., et al. Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Arch Dermatol 2008, 144:217-222.
24. Ataie-Jafari A., Rahmat A., Abbasi F., Loke S.C., Qorbani M., et al. Vitamin D status and associated factors in recent-onset type 1 diabetic children in Iran. JDiabetes Metab Disorders 2012, 11:12.
25. Olson C.L. On choosing a test statistic in multivariate analysis of variance. Psychol Bull 1976, 83:579.
26. Faul F., Erdfelder E., Buchner A., Lang A.G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009, 41:1149-1160.
27. Cohen J. Statistical power analysis for the behavioral sciences 1988, L. Erlbaum Associates.
28. Monnier L., Colette C., Dunseath G.J., Owens D.R. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007, 30:263-269.
29. Ponsonby A.L., McMichael A., van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002, 181-182:71-78.
30. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
31. Walter M., Kaupper T., Adler K., Foersch J., Bonifacio E., et al. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 2010, 33:1443-1448.
32. Marcus R. Agents affecting calcification and bone turnover. Goodman and Gilman's: the pharmacological basis of therapeutics 1996, 1519-1546. McGraw-Hill, New York. 9th ed. J. Hardman, L. Limbird (Eds.).
33. Ergun-Longmire B., Marker J., Zeidler A., Rapaport R., Raskin P., et al. Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes. Ann N Y Acad Sci 2004, 1029:260-277.
34. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010, 7. e1000251.